Loading...

SCHOTT Pharma AG & Co. KGaA

1SXP.FXETRA
HealthcareMedical - Instruments & Supplies
28.65
-0.15(-0.52%)

SCHOTT Pharma AG & Co. KGaA 1SXP.F Peers

See (1SXP.F) competitors and their performances in Stock Market.

Peer Comparison Table: Medical - Instruments & Supplies Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
1SXP.F€28.65-0.52%4.3B32.19€0.89+0.56%
PHIA.DE€48.00N/A43.4B13.73€3.50+4.16%
BTL.DE€58.80N/A29.6B30.31€1.94N/A
SRT.DE€176.40-0.45%13.7B127.83€1.38+0.41%
SRT3.DE€219.20-0.95%13.6B160.00€1.37+0.33%
AFX.DE€58.25-2.43%5.1B32.91€1.77+1.01%
FIE.DE€55.80-1.06%4.7B30.83€1.81+1.77%
GXI.DE€64.05+5.00%2.2B28.09€2.28+2.05%
MYD.DE€26.72N/A2.2B-256.92-€0.10N/A
2B4.F€23.16+0.52%1.5B136.24€0.17N/A
Showing 1 to 10 of 11 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

1SXP.F vs PHIA.DE Comparison

1SXP.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 1SXP.F stands at 4.3B. In comparison, PHIA.DE has a market cap of 43.4B. Regarding current trading prices, 1SXP.F is priced at €28.65, while PHIA.DE trades at €48.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

1SXP.F currently has a P/E ratio of 32.19, whereas PHIA.DE's P/E ratio is 13.73. In terms of profitability, 1SXP.F's ROE is +0.17%, compared to PHIA.DE's ROE of +0.03%. Regarding short-term risk, 1SXP.F is more volatile compared to PHIA.DE. This indicates potentially higher risk in terms of short-term price fluctuations for 1SXP.F.

Stock Price Comparison

Loading...

Frequently Asked Questions